Primary study · included by 1 review
A Retrospective Cross-Sectional Study of the Effect of Liposomal Bupivacaine on Postoperative Opioid Prescribing After Third Molar Extraction.
Lieblich 2021 · Lieblich Stuart E, Misiek Dale, Olczak John, et al. · Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2021
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Postoperative pain intensity (VAS/NRS) Liposomal bupivacaine infiltration vs Standard bupivacaine or placebo · 0-48 hours | SMD -0.21 [-0.51, 0.10] | 2 studies · 168 participants | GRADE not reported |
Total opioid prescription at 48 hours (MME) Liposomal bupivacaine infiltration vs Standard bupivacaine or placebo (non-LB control) · 48 hours | MD -66.70 [-72.96, -60.44] | 1 study · 600 participants | GRADE not reported |
1 including review in total.